Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sip2Sleep is a natural, plant-based sleep aid formulation consisting of Montmorency tart cherry extract and Venetron, a purified extract of *Apocynum venetum* (Rafuma). Developed by Lakshmi Nutraceuticals and created by Dr. Ruchir P. Patel, the product is designed to address sleep disorders including insomnia and anxiety. The *Apocynum venetum* component is clinically shown to increase GABA levels, promoting relaxation and improving sleep quality, while the tart cherry extract provides natural sources of melatonin and anthocyanins to support the sleep-wake cycle. Clinical studies conducted by People Science have demonstrated that the mixture statistically improves subjective sleep quality, daytime alertness, and insomnia symptoms without significantly impacting sleep duration or latency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sip2Sleep.